InsiderClue
Stocks · Health care · Medicinal Chemicals & Botanical Products

biote Corp.

BTMD Clue Score64
United States Fiscal year ends December CIK 0001819253
$1.15 -1.71% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.15 −88.21% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue139.4Operating income34.6Net income11.1Fiscal year 2022Revenue165.0 +18.3%Operating income−60.7Net income−1.0 −108.7%EPS, diluted−0.12Fiscal year 2023Revenue185.4 +12.4%Operating income28.7Net income3.3EPS, diluted0.13Fiscal year 2024Revenue197.2 +6.4%Operating income31.6Net income3.2 −4.8%EPS, diluted0.09Fiscal year 2025Revenue192.2 −2.5%Operating income35.6Net income27.0 +756.7%EPS, diluted0.74
FY2021FY2022FY2023FY2024FY2025
Revenue 139.4 165.0 185.4 197.2 192.2
Growth +18.3% +12.4% +6.4% −2.5%
Operating income 34.6 −60.7 28.7 31.6 35.6
Net income 11.1 −1.0 3.3 3.2 27.0
Growth −108.7% −4.8% +756.7%
EPS, diluted n/a −0.12 0.13 0.09 0.74

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2021Operating margin24.8%Net margin8.0%Free cash flow margin23.2%Fiscal year 2022Operating margin−36.8%Net margin−0.6%Free cash flow margin−5.8%Fiscal year 2023Operating margin15.5%Net margin1.8%Free cash flow margin14.3%Fiscal year 2024Operating margin16.0%Net margin1.6%Free cash flow margin19.7%Fiscal year 2025Operating margin18.5%Net margin14.1%Free cash flow margin15.7%
FY2021FY2022FY2023FY2024FY2025
Operating margin 24.8% −36.8% 15.5% 16.0% 18.5%
Net margin 8.0% −0.6% 1.8% 1.6% 14.1%
Free cash flow margin 23.2% −5.8% 14.3% 19.7% 15.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow33.7Capital expenditure−1.4Free cash flow32.3Dividends paid−11.4Fiscal year 2022Operating cash flow−9.2Capital expenditure−0.3Free cash flow−9.5 −129.4%Dividends paid−12.9Fiscal year 2023Operating cash flow26.9Capital expenditure−0.4Free cash flow26.5Dividends paid−8.7Fiscal year 2024Operating cash flow45.2Capital expenditure−6.4Free cash flow38.8 +46.3%Buybacks−5.6Dividends paid−4.7Fiscal year 2025Operating cash flow35.2Capital expenditure−5.0Free cash flow30.2 −22.2%Buybacks−3.4Dividends paid−1.7
FY2021FY2022FY2023FY2024FY2025
Operating cash flow 33.7 −9.2 26.9 45.2 35.2
Capital expenditure −1.4 −0.3 −0.4 −6.4 −5.0
Free cash flow 32.3 −9.5 26.5 38.8 30.2
Growth −129.4% +46.3% −22.2%
Buybacks n/a n/a n/a −5.6 −3.4
Dividends paid −11.4 −12.9 −8.7 −4.7 −1.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.1Total debt37.0Net cash (debt)−36.8Shareholders’ equity4.1Debt to equity8.96Fiscal year 2022Cash79.2Total debt118.3Net cash (debt)−39.1Shareholders’ equity−44.5Fiscal year 2023Cash89.0Total debt112.9Net cash (debt)−23.9Shareholders’ equity−29.4Fiscal year 2024Cash39.3Total debt107.4Net cash (debt)−68.1Shareholders’ equity−105.9Fiscal year 2025Cash24.1Total debt102.0Net cash (debt)−77.9Shareholders’ equity−58.5
FY2021FY2022FY2023FY2024FY2025
Cash 0.1 79.2 89.0 39.3 24.1
Total debt 37.0 118.3 112.9 107.4 102.0
Net cash (debt) −36.8 −39.1 −23.9 −68.1 −77.9
Shareholders’ equity 4.1 −44.5 −29.4 −105.9 −58.5
Debt to equity 8.96 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
139.4 165.0 185.4 197.2 192.2
Growth +18.3% +12.4% +6.4% −2.5%
49.1 171.1 98.8 107.5 101.8
34.6 −60.7 28.7 31.6 35.6
Growth −275.7% +10.3% +12.5%
32.9 1.7 −0.1 1.0 37.6
0.3 0.4 2.7 1.0 6.0
11.1 −1.0 3.3 3.2 27.0
Growth −108.7% −4.8% +756.7%
Per share
n/a −0.12 0.13 0.09 0.86
n/a −0.12 0.13 0.09 0.74
Growth −30.8% +722.2%
n/a 8.1 25.7 34.3 31.3
n/a 8.1 25.7 34.3 36.7
Growth +219.0% +33.3% +7.0%

† The diluted share count jumps at 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 1 of 5 years on file.